Viral infections are a leading cause of myocarditis and pericarditis worldwide, conditions that
frequently coexist. Myocarditis and pericarditis were some of the early comorbidities …

In the last years, major progress occurred in heart failure (HF) management. Quadruple
therapy is now mandatory for all the patients with HF with reduced ejection fraction. Whilst …

Aims To explore the incidence and potential mechanisms of oligosymptomatic myocardial
injury following COVID‐19 mRNA booster vaccination. Methods and results Hospital …

Worldwide there have been over 760 million confirmed coronavirus disease 2019 (COVID-
19) cases, and over 13 billion COVID-19 vaccine doses have been administered as of April …

Abstract Background The Pfizer BioNTech COVID-19 vaccine was the first to receive
emergency authorization and approval from the FDA. Therefore, it is preferred by most …

Abstract Purpose of Review Cardiac consequences occur in both acute COVID-19 and post-
acute sequelae of COVID-19 (PASC). Here, we highlight the current understanding about …

SARS-CoV-2 vaccine–associated myocarditis/myocardial injury should be evaluated in the
contexts of COVID-19 infection, other types of viral myocarditis, and other vaccine …

mRNA vaccines against respiratory viruses : Current Opinion in Infectious Diseases mRNA
vaccines against respiratory viruses : Current Opinion in Infectious Diseases Log in or Register …

The SARS-CoV-2 (severe acute respiratory syndrome coronavirus responsible for the
COVID-19 disease) uses the Spike proteins of its envelope for infecting target cells …

Autoimmune cardiopathies (AC) following COVID-19 and vaccination against SARS-CoV-2
occur at significant rates but are of unknown etiology. This study investigated the possible …